Search Results

There are 2103 results for: content related to: Fighting, Negotiating, Laughing: The Use of Humor in the V ietnam War

  1. Soviet Biscuit Factories and Chinese Financial Grants: North Vietnam's Economic Diplomacy in 1967 and 1968

    Diplomatic History

    Volume 36, Issue 2, April 2012, Pages: 301–335, HARISH C. MEHTA

    Article first published online : 23 FEB 2012, DOI: 10.1111/j.1467-7709.2011.01024.x

  2. You have free access to this content
    Thermodynamic and structural analysis of HIV protease resistance to darunavir – analysis of heavily mutated patient-derived HIV-1 proteases

    FEBS Journal

    Volume 281, Issue 7, April 2014, Pages: 1834–1847, Milan Kožíšek, Martin Lepšík, Klára Grantz Šašková, Jiří Brynda, Jan Konvalinka and Pavlína Řezáčová

    Article first published online : 28 FEB 2014, DOI: 10.1111/febs.12743

  3. You have free access to this content
    Autocatalytic maturation, physical/chemical properties, and crystal structure of group N HIV-1 protease: Relevance to drug resistance

    Protein Science

    Volume 19, Issue 11, November 2010, Pages: 2055–2072, Jane M. Sayer, Johnson Agniswamy, Irene T. Weber and John M. Louis

    Article first published online : 29 SEP 2010, DOI: 10.1002/pro.486

  4. Pharmacokinetic Interactions Between Darunavir/Ritonavir and Opioid Maintenance Therapy Using Methadone or Buprenorphine/Naloxone

    The Journal of Clinical Pharmacology

    Volume 51, Issue 2, February 2011, Pages: 271–278, Dr Vanitha Sekar, Dr Frank Tomaka, Dr Eric Lefebvre, Dr Martine De Pauw, Dr Tony Vangeneugden, Dr Wim van den Brink and Dr Richard Hoetelmans

    Article first published online : 7 MAR 2013, DOI: 10.1177/0091270010365558

  5. You have free access to this content
    Final 192-week efficacy and safety of once-daily darunavir/ritonavir compared with lopinavir/ritonavir in HIV-1-infected treatment-naïve patients in the ARTEMIS trial

    HIV Medicine

    Volume 14, Issue 1, January 2013, Pages: 49–59, C Orkin, E DeJesus, H Khanlou, A Stoehr, K Supparatpinyo, E Lathouwers, E Lefebvre, M Opsomer, T Van de Casteele and F Tomaka

    Article first published online : 23 OCT 2012, DOI: 10.1111/j.1468-1293.2012.01060.x

  6. Evaluation of Atazanavir and Darunavir Interactions with Lipids for Developing pH-Responsive Anti-HIV Drug Combination Nanoparticles

    Journal of Pharmaceutical Sciences

    Volume 103, Issue 8, August 2014, Pages: 2520–2529, Jinghua Duan, Jennifer P. Freeling, Josefin Koehn, Cuiling Shu and Rodney J. Y. Ho

    Article first published online : 19 JUN 2014, DOI: 10.1002/jps.24046

  7. Effect of protein binding on unbound atazanavir and darunavir cerebrospinal fluid concentrations

    The Journal of Clinical Pharmacology

    Volume 54, Issue 9, September 2014, Pages: 1063–1071, Cecile A. Delille, Sarah T. Pruett, Vincent C. Marconi, Jeffrey L. Lennox, Wendy S. Armstrong, Richard F. Arrendale, Anandi N. Sheth, Kirk A. Easley, Edward P. Acosta, Aswani Vunnava and Ighovwerha Ofotokun

    Article first published online : 8 APR 2014, DOI: 10.1002/jcph.298

  8. You have free access to this content
    Critical differences in HIV-1 and HIV-2 protease specificity for clinical inhibitors

    Protein Science

    Volume 21, Issue 3, March 2012, Pages: 339–350, Yunfeng Tie, Yuan-Fang Wang, Peter I. Boross, Ting-Yi Chiu, Arun K. Ghosh, Jozsef Tozser, John M. Louis, Robert W. Harrison and Irene T. Weber

    Article first published online : 24 JAN 2012, DOI: 10.1002/pro.2019

  9. You have free access to this content
    Pharmacokinetic interaction between nevirapine and darunavir with low-dose ritonavir in HIV-1-infected patients

    British Journal of Clinical Pharmacology

    Volume 68, Issue 1, July 2009, Pages: 116–119, Vanitha Sekar, Eric Lefebvre, Kris Mariën, Martine De Pauw, Tony Vangeneugden, Anton Pozniak and Richard M. W. Hoetelmans

    Article first published online : 5 MAY 2009, DOI: 10.1111/j.1365-2125.2009.03430.x

  10. Highly conserved glycine 86 and arginine 87 residues contribute differently to the structure and activity of the mature HIV-1 protease

    Proteins: Structure, Function, and Bioinformatics

    Volume 78, Issue 4, March 2010, Pages: 1015–1025, Rieko Ishima, Qingguo Gong, Yunfeng Tie, Irene T. Weber and John M. Louis

    Article first published online : 28 SEP 2009, DOI: 10.1002/prot.22625

  11. You have free access to this content
    The MONET trial: week 144 analysis of the efficacy of darunavir/ritonavir (DRV/r) monotherapy versus DRV/r plus two nucleoside reverse transcriptase inhibitors, for patients with viral load < 50 HIV-1 RNA copies/mL at baseline

    HIV Medicine

    Volume 13, Issue 7, August 2012, Pages: 398–405, JR Arribas, N Clumeck, M Nelson, A Hill, Y van Delft and C Moecklinghoff

    Article first published online : 13 MAR 2012, DOI: 10.1111/j.1468-1293.2012.00989.x

  12. You have free access to this content
    Subgroup analysis of virological response rates with once- and twice-daily darunavir/ritonavir in treatment-experienced patients without darunavir resistance-associated mutations in the ODIN trial

    HIV Medicine

    Volume 14, Issue 7, August 2013, Pages: 437–444, M Sension, P Cahn, P Domingo, S Hodder, M Opsomer, E Lathouwers, T Van de Casteele and F Tomaka

    Article first published online : 10 MAR 2013, DOI: 10.1111/hiv.12024

  13. The FDA Approved HIV-1 Protease Inhibitors for Treatment of HIV/AIDS

    Standard Article

    Burger's Medicinal Chemistry and Drug Discovery

    Arun K. Ghosh, David D. Anderson and Hiroaki Mitsuya

    Published Online : 27 AUG 2010, DOI: 10.1002/0471266949.bmc224

  14. Early lipid changes with atazanavir/ritonavir or darunavir/ritonavir

    HIV Medicine

    Volume 15, Issue 6, July 2014, Pages: 330–338, E Martinez, A Gonzalez-Cordon, E Ferrer, P Domingo, E Negredo, F Gutierrez, J Portilla, A Curran, D Podzamczer, J Murillas, JI Bernardino, I Santos, JA Carton, J Peraire, J Pich, I Perez, JM Gatell and for the ATADAR Study Group

    Article first published online : 12 JAN 2014, DOI: 10.1111/hiv.12121

  15. Efficacy and safety of once-daily maraviroc plus ritonavir-boosted darunavir in pretreated HIV-infected patients in a real-life setting

    HIV Medicine

    Volume 15, Issue 7, August 2014, Pages: 417–424, J Macías, E Recio, M Márquez, C García, P Jiménez, D Merino, L Muñoz, J Pasquau, G Ojeda, P Bancalero, N Chueca and JA Pineda

    Article first published online : 24 FEB 2014, DOI: 10.1111/hiv.12129

  16. One-step production of darunavir solid dispersion nanoparticles coated with enteric polymers using electrospraying

    Journal of Pharmacy and Pharmacology

    Duong Nhat Nguyen, Ljiljana Palangetic, Christian Clasen and Guy Van den Mooter

    Article first published online : 14 AUG 2015, DOI: 10.1111/jphp.12459

  17. Development and validation of a rapid ultra high performance liquid chromatography with tandem mass spectrometry method for the simultaneous determination of darunavir, ritonavir, and tenofovir in human plasma: Application to human pharmacokinetics

    Journal of Separation Science

    Volume 38, Issue 15, August 2015, Pages: 2580–2587, Ambavaram Vijaya Bhaskar Reddy, Jafariah Jaafar, Azmi Bin Aris, Zaiton Abdul Majid, Khalid Umar, Juhaizah Talib and Gajulapalle Madhavi

    Article first published online : 18 JUN 2015, DOI: 10.1002/jssc.201500250

  18. You have free access to this content
    Pc5 micropulsation power at conjugate high-latitude locations

    Journal of Geophysical Research: Space Physics (1978–2012)

    Volume 108, Issue A4, April 2003, Paola Ballatore

    Article first published online : 4 APR 2003, DOI: 10.1029/2002JA009600

  19. Efficacy of etravirine combined with darunavir or other ritonavir-boosted protease inhibitors in HIV-1-infected patients: an observational study using pooled European cohort data

    HIV Medicine

    Volume 16, Issue 5, May 2015, Pages: 297–306, J Vingerhoets, V Calvez, P Flandre, A-G Marcelin, F Ceccherini-Silberstein, C-F Perno, M Mercedes Santoro, R Bateson, M Nelson, A Cozzi-Lepri, J Grarup, J Lundgren, F Incardona, R Kaiser, A Sonnerborg, B Clotet, R Paredes, HF Günthard, B Ledergerber, A Hoogstoel, S Nijs, L Tambuyzer, L Lavreys, M Opsomer and on behalf of the Etravirine Cohort Study Group

    Article first published online : 14 JAN 2015, DOI: 10.1111/hiv.12218

  20. Interactions of different inhibitors with active-site aspartyl residues of HIV-1 protease and possible relevance to pepsin

    Proteins: Structure, Function, and Bioinformatics

    Volume 75, Issue 3, 15 May 2009, Pages: 556–568, Jane M. Sayer and John M. Louis

    Article first published online : 17 SEP 2008, DOI: 10.1002/prot.22271